107667-60-7 Usage
Description
Polaprezinc, a complex of zinc ion and L-carnosine, is an antiulcer agent
launched in Japan. It is effective in promoting the healing of gastric ulcers in
addition to preventing ulcer relapse. In rat studies, polaprezinc reduces the
incidence of stomach lesions induced by ethanol. No effect was seen on
ultrastructural damage or on cell proliferation and it appears that polaprezinc
combines the cytoprotective effect of zinc with the ulcer healing properties of Lcarnosine.
The in vivo antioxidative properties of polaprezinc has been suggested
to be responsible for its protective effect against gastric mucosal injury. Recent studies revealed that polaprezinc is an activator of bone formetion and
has inhibitory effect of bone resorption. This agent is thus able to prevent the
deterioration of bone metabolism indicating its potential usefulness in the treatment
of osteoporosis. Polaprezinc has also been claimed for the prophylaxis and
treatment of alcoholic hepatopathy, viral hepatitis or other hepatopathies caused by
certain drugs, poisons and radiation.
Chemical Properties
White To Pale-Yellow Crystalline Solid
Originator
Hamari Chemicals (Japan)
Uses
Different sources of media describe the Uses of 107667-60-7 differently. You can refer to the following data:
1. A novel anti-gastric ulcer agent
2. PepZinGI(R) is a new dietary supplement approved by the federal agency. Don`t hesitate to contact us for more information. Attributes New dietary supplement Contact
3. anti-ulcer drug, antioxidative,
Brand name
Promac
Check Digit Verification of cas no
The CAS Registry Mumber 107667-60-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,6,6 and 7 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 107667-60:
(8*1)+(7*0)+(6*7)+(5*6)+(4*6)+(3*7)+(2*6)+(1*0)=137
137 % 10 = 7
So 107667-60-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H14N4O3.Zn/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6;/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16);/q;+2
107667-60-7Relevant articles and documents
Methods for producing L-carnosine zinc complex
-
Paragraph 0021; 0022, (2017/06/20)
Disclosed is a method for conveniently synthesizing, at high purity and high yield, a crystalline L-carnosine zinc complex which is useful as an antiulcer treatment agent without having a separate refining step. A method for producing an L-carnosine zinc complex comprises the steps of: suspending L-carnosine and zinc salts in an alcohol or a water-containing alcohol; producing an alkali metal compound solution by dissolving an alkali metal compound in an alcohol or a water-containing alcohol; precipitating an L-carnosine zinc complex by adding the alkali metal compound solution in a suspension of the L-carnosine and the zinc salts; adding refined water in a reactive liquid including the L-carnosine zinc complex; and filtering an L-carnosine zinc complex crystal.COPYRIGHT KIPO 2017